Immunotherapy Combination Approved for Colorectal Cancer - NCI
Frontiers | Colorectal Cancer Immunotherapy: Options and Strategies
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Rectal Cancer Disappears After Experimental Use of Immunotherapy | Memorial Sloan Kettering Cancer Center
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
Key immunotherapy trials in metastatic colorectal cancer (CRC). | Download Table
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | NEJM
Clinical trials of immunotherapy in colorectal cancer | Download Scientific Diagram
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Cells | Free Full-Text | Immunotherapy, Inflammation and Colorectal Cancer
View of The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation | Annals of Gastroenterology
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy - ScienceDirect
Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Colorectal Cancer Clinical Trials | Fight Colorectal Cancer
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal 'Immunoablative' Neoadjuvant Immunotherapy Clinical Trial | Memorial Sloan Kettering Cancer Center
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Frontiers | Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer
Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update - ScienceDirect
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
Colorectal Cancer Clinical Trials | Fight Colorectal Cancer
